Trial intelligence / Profile preview

Continuing Dasatinib Treatment for Prior Trial Participants

2014-004278-40Phase 2Completed

Sponsor

Bristol Myers Squibb

Start

Sep 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1